A method for preventing complications from the operations HIGH RISK INFANTS WITH PATHOLOGY OF LOCOMOTOR SYNDROME AND INCREASED thymus

摘要

1.method for prevention of complications in high risk u043eu043fu0435u0440u0430u0446u0438u00a0u0445 children an early age with symptoms of musculoskeletal system and increased u0432u0438u043bu043eu0447u043au043e syndrome your glands by u0432u0432u0435u0434u0435u043du0438u00a0 some cortisone for u043eu0442u043bu0438u0447u0430u044eu0449u0438u0439u0441u00a0 so that if a child of an enlarged thymus 1 to 3 degrees at the same time given prednisolone and u044du0443u0431u0438u043eu0442u0438u043au0438,and in the second and third degree further u0438u043cu043cu0443u043du043eu043cu043eu0434u0443u043bu00a0u0442u043eu0440u044b;2. method for prevention of complications in high risk u043eu043fu0435u0440u0430u0446u0438u00a0u0445 children an early age with symptoms of musculoskeletal system and increased u0432u0438u043bu043eu0447u043au043e syndrome your glands for p.1, u043eu0442u043bu0438u0447u0430u044eu0449u0438u0439u0441u00a0, with enlarged thymus had first degree u0432u0432u043eu0434u00a0u0442 prednisolone in u043fu0440u0435u0434u043eu043fu0435u0440u0430u0446u0438u043eu043du043du044bu0439, surgical and postoperative days in dose of 0.7 to 0.9 mg / kg, with an enlarged thymus had second degree, and the planning of the operation risk in u0442u0435u0447u0435u043du0438 u0432u0432u043eu0434u00a0u0442 intramuscular prednisolone e two days in u0434u043eu043eu043fu0435u0440u0430u0446u0438u043eu043du043eu043c periodon the day of surgery and two u0434u043du00a0 after surgery in a dose of 1.0 to 1.5 mg / kg, and with an enlarged thymus had third degree dose prednisolone increased to 1.6 - 2 mg / kg with the simultaneous introduction of u0438u043cu043cu0443u043du043eu043cu043eu0434u0443u043bu00a0u0442u043eu0440u043eu0432: u0442u0430u043au0442u0438u0432u0438u043du0430 in a dose of 3 mg / kg subcutaneous within two days before and two days after operation or u043bu0438u043au043eu043fu0438u0434u0430 in a dose of 0.5 mg of two ra for a day u0441u0443u0431u043bu0438u043du0433u0432u0430u043bu044cu043du043e.;3. method for prevention of complications in high risk u043eu043fu0435u0440u0430u0446u0438u00a0u0445 children an early age with symptoms of musculoskeletal system and increased u0432u0438u043bu043eu0447u043au043e syndrome your glands 1, u043eu0442u043bu0438u0447u0430u044eu0449u0438u0439u0441u00a0, with u0434u043du00a0 u043fu043eu0441u0442u0443u043fu043bu0435u043du0438u00a0 patient designate u044du0443u0431u0438u043eu0442u0438u043au0438: u0431u0438u0444u0438u0434u0443u043c - u043bu0430u043au0442u043eu0431u0430u043au0442u0435u0440u0438u043d for 3-5 doses three times a day or bl is set to 3 to 5 ml of a ra from the day our 1 capsule 2 to 3 times a day for 7 to 10 days.